GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $243,000 | -90.9% | 5,000 | -90.2% | 0.02% | -90.9% |
| Q2 2019 | $2,683,000 | -20.7% | 51,000 | -20.2% | 0.16% | -21.9% |
| Q1 2019 | $3,382,000 | +50.0% | 63,900 | +16.4% | 0.21% | +38.2% |
| Q4 2018 | $2,254,000 | +80.3% | 54,900 | +66.9% | 0.15% | +108.2% |
| Q3 2018 | $1,250,000 | -34.5% | 32,900 | -55.8% | 0.07% | -36.0% |
| Q2 2018 | $1,909,000 | -18.7% | 74,500 | -1.3% | 0.11% | -24.0% |
| Q1 2018 | $2,349,000 | -17.9% | 75,500 | +3.9% | 0.15% | -16.7% |
| Q4 2017 | $2,861,000 | +101.6% | 72,700 | +59.1% | 0.18% | +63.6% |
| Q3 2017 | $1,419,000 | +13.5% | 45,700 | 0.0% | 0.11% | +8.9% |
| Q2 2017 | $1,250,000 | – | 45,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |